I-Orlistat powder
I-CMOAPI ngowona mvelisi mkhulu we-Orlistat e-China, ene-1800KG amandla kwiinyanga nganye, kwaye inolawulo olubanzi lweenkqubo zolawulo lomgangatho (ISO19001) kunye nenkqubo yolawulo lokusingqongileyo (14001).
Ulwazi lwe-Orlistat powder Base
| igama | I-Orlistat powder |
| Ukuthanda | Powstalline powder |
| Iimeko | 96829-58-2 |
| IAsay | ≥99% |
| Umzimba | I-nsoluble emanzini okanye yotywala, inyibilika kwi-Acetic acid, i-ethyl ester. |
| Isisindo somzimba | 495.7 g / mol |
| Melt Point | 50 ° C |
| I-Molecular Formula | C9H7ClN2O5 |
| Isistim | 30mg |
| ukugcinwa Temp | 2-8 ° C Ifreyiza |
| kwiBanga | KwiGrade yeBanga |
Iziphumo ezilahlekileyo kunye nokuKhawuleza kokuPhulukana noMzimba kwi-Orlistat Powder
Sebenzisa ubunyulu 99.7% yokulahleka kobunzima okanye i-orlistat powder eyenziweyo ukuze inyibilike amanqatha nokuba abaguli bayala ukwenza umthambo! I-Orlistat Powder evela kumenzi we-CMOAPI uphumelele ngempumelelo isatifikethi se-GMP kunye ne-DMF, esisisiqinisekiso sokugqibela esinokuhambisa iimveliso ezikumgangatho ophezulu kubathengi bethu. Kwaye umgangatho uguqulela ngokuthe ngqo kubathengi abonwabileyo, ukonyusa ukuthengisa, kunye nomfanekiso wohlobo lophuculo.
Yintoni iOrlistat Powder
I-Orlistat powder yipilisi eyilelwe ukunceda abaguli abachasene nokukhuluphala, into esebenzayo yi-orlistat, ukudibanisa i-Orlistat kunye nekhalori encitshisiweyo egadiweyo kunye nokutya okunamafutha asezantsi, inokwandisa kakhulu ukusebenza kwayo ngenxa yokukwazi ukuvimba ukufunxwa kwamafutha kwindawo yokugaya ukutya. Ke intengiso eninzi yokulahleka kobunzima enokuthi ibonwe njenge-orlistat powder isebenzisa ukunciphisa ukutya kunye nokuqokelelwa kwamafutha. Njengemithi yonyango, i-Orlistat ithengiswe phantsi kwegama lophawu "Xenical", kananjalo njengechiza lokulwa nokutyeba ngaphezulu kwe-counter phantsi kwegama lorhwebo "Alli".
Izifundo zeklinikhi ezenziwe kwi-orlistat powder zavumela abaphandi abaphuhlise ifomula ukuba bavelise ikhompawundi yokulahleka kwesisindo esinamandla kangangokuba amanqatha amabi adityaniswa kwangoko kwaye iziphumo zibonwa kwiiveki ezi-2 kuphela. Uvavanyo lobunzululwazi oluntsonkothileyo lwaluyimfuneko ukuze kufunyanwe kanye ukuba kutheni le nto ivelisa iziphumo zokuphulukana nomzimba ngokumangalisayo.
Ingaba kwenzeka njani Umsebenzi wePowderat Powder & Iziphumo ziyamangalisa
I-Orlistat powder yindlela ekhethiweyo yokuthintela ii-enzymes ezaphula amanqatha kwindawo yokugaya ukutya. Ukuba sithatha ikhalori engaphaya kokutya kukhokelela ekugcineni ukungafuneki njengamafutha, kuya kubangela ukutyeba. I-Orlistat powder isebenza ngokunciphisa inani lamafutha omzimba afunwa kukutya. Nje ukuba iqhotyoshelwe kwi-enzyme yesisu kunye nepancreatic lipase yenza iqhina elidibeneyo elithintela ii-enzymes kwi-hydrolyzing fat diet kwi-fatty acids kunye ne-monoglycerides.
Olunye uphononongo lubonisa ukuba i-Orlistat ye-powder dosage yi-120 mg, inani lamafutha avaliweyo limalunga ne-30% yamafutha etyiwayo mihla le. Amafutha angacaciswanga adlula kwinkqubo kwaye apheliswe njengenkunkuma. Isebenza ngokuthintela isisu kunye nepancreatic lipases. Ezi zii-enzymes ezonakalisa amanqatha okutya (i-triglycerides) kwifomu enokufakwa, ii-acid ezinamafutha okanye i-monoglycerides.
Indlela yokusebenzisa i-Orlistat Powder
Isigulana kufuneka sithathe i-orlistat powder dose ngamanzi kwindawo nganye yokutya enamafutha ukuya kuthi ga kuma-3 ngemini ukuya kuthi ga kwiyure enye emva kwesidlo. Isidlo ngasinye akufuneki sibe ngaphezulu kwe-30% yeekhalori zayo kumanqatha.
Kuba i-orlistat powder inefuthe ekufunxweni kweevithamini ezinamafutha anqamleza njenge-A, D, E, kunye no-K, kuyacetyiswa kakhulu ukuba izigulana zithathe izongezo ezifanelekileyo zemihla ngemihla ze-orlistat ukubuyekeza nakuphi na ukusilela. Ixesha lokungenisa i-orlistat elongezelweyo lokuthatha ixesha elincinci li-2 iiyure ngaphambi okanye iiyure ze-2 emva kokuthatha i-orlistat.
Le fomyula ye-orlistat powder iyasebenza kakhulu ekuveliseni ukulahleka kwesisindo ukuba abaguli bangaqala ukubona nokuziva umzimba utshintsha kwiiveki ezi-2 kuphela! Unyango olufanelekileyo nge-Orlistat Powder elandela imiyalelo elula inokuguqula iminyaka yokutya kakhulu.
Isilumkiso esibalulekileyo kwi-Orlistat Powder
IBallance sisibonelelo sokwenyani emva kokusebenzisa i-orlistat powder
- I-Orlistat powder yenziwe ukuba ukunceda abaguli ukubetha ukutyeba kunye nobunzima obugqithisileyo. Ukusetyenziswa kwayo ngabantu abajolise ekubeni babe semngciphekweni oyingozi kufuneka kuthintelwe njengezenzo ezingenampilo neziyingozi.
- Ngaphandle kokuncipha kokutya, abaguli abaphantsi konyango lwe-Orlistat powder kufuneka balandele ukutya okusempilweni ngaphandle kokuzinciphisa zonke izondlo.
- Uvavanyo olupheleleyo lonyango lwangaphambi kokuqinisekisa imeko eqhelekileyo yempilo inyanzelekile.
- Iziphumo eziqhelekileyo ze-Orlistat zeempembelelo zesisu kwaye zenzeka ngenxa yeoli engagqithwanga ehamba kwinkqubo yokutya.
- Iziphumo zeempembelelo ze-Orlistat zenzeka kwiiveki zokuqala zolawulo kwaye zinokuphela. Nangona kunjalo, ezinye iimpawu zisenokuqhubeka.
- Ezinye iziphumo ezinokubangelwa kukungalunganga kwe-orlistat powder powder, ngoko ke ngokungqongqo ukulandela amayeza kubalulekile.
- Kuya kufuneka kugxininiswe ngamandla ukuba ukwanda kweedosi ze-Orlistat powder akubangeli ziphumo zinamandla ngakumbi kodwa kunokuba kubangele iimpendulo ezimbi.
Unemibuzo? Iingcali zethu zilapha kwaye ziphendulaUvavanyo lwe-orlistat powder
Ngubani Benefits From Orlistat Pityala?
I-Orlistat powder ngumncedisi onamandla kunoma yiphina imeko efuna ukukhutshwa ngokukhawuleza nangokufanelekileyo kwamafutha omzimba.
1).Ukunyanga ukutyeba okuphuculweyo nge-Orlistat
Ngama-39% abemi behlabathi abanengxaki yokufumba okuninzi kwamafutha emzimbeni, ukutyeba yenye yeengxaki zempilo yoluntu ezaziwayo kwihlabathi liphela. Imingcipheko enokubakho ebandakanya, njengokuphazamiseka kwentliziyo, isifo seswekile, umhlaza othile, kunye noxinzelelo lwegazi, kunyanzelekile ukuba kuthathwe amanyathelo akhawulezileyo kunye nefanelekileyo - okucwangcisiweyo, okubekwe esweni, kunye nokulawulwa kokunciphisa umzimba.
Ngokufanelekileyo, isicwangciso sokulahleka kwesisindo siqukethe ukutya okulungiselelwe, ukuzivocavoca, kwaye apho kunyanzelekile amayeza, kwaye kuthathwa njengempumelelo xa kukhokelela kwi-5% yokunciphisa umzimba kungaphelanga unyaka.
I-Orlistat sisiyobisi esinamandla nesisebenzayo sokulahleka kobunzima esiqinisekiswe ukuba sinegalelo elibonakalayo ekufezekiseni injongo yokunciphisa umzimba. Uphononongo olubandakanya abathathi-nxaxheba abangaphezu kwe-3,305 abatyebe kakhulu bavavanya isiphumo sokulawula i-120 mg Orlistat kathathu mihla le kangangeminyaka emi-4 idityaniswe nekhalori ephantsi, i-30% -ukutya ukutya kunye nokukhanya kwemihla ngemihla. Iziphumo zibonise ukwehla komndilili we-10.6 kg kunyaka wokuqala. Ukuphulukana nobunzima ngokuthobekileyo kuqinisekisa ukuba abaguli babugcina ubunzima okanye bade banciphise ubunzima ngesicwangciso sokulahleka kwesisindo.
2). Umngcipheko wohlobo lwe-2 yeswekile luyancitshiswa nge-Orlistat
Uhlobo lwe-2 yeswekile okanye isifo seswekile sisimo esibi esonakalisa imetabolism emzimbeni. Inxulunyaniswa nokumelana ne-insulin okanye ukungonelanga kwemveliso ye-insulin yipancreas, kwaye ke ngenxa yoko ukungakwazi ukugcina amanqanaba eswekile afanelekileyo emzimbeni. Ukungahoyi iimpawu zokuqala njengokunyuka kwenxano, ukunciphisa umzimba ngokungakhathali, ukudinwa, ukungaboni kakuhle, ukusuleleka rhoqo, kunye nokuphulukana namanxeba nokungawaphenduli ngokufanelekileyo kunokubangela iingxaki ezinje ngoxinzelelo lwegazi, izifo zentliziyo, kunye nentliziyo. Ke ngoko, unyango lwangexesha nolufanelekileyo lubalulekile ekuphepheni ukukhula kwemicimbi yezempilo engaphezulu.
Njengesidakamizwa esinamandla sokulahleka kwesisindo, i-Orlistat powder idlala indima ebalulekileyo ekukhuseleni ukuqala kohlobo lwe-2 yeswekile. Iziphumo ze powder ze-Orlistat zinokuphucula uvakalelo lwe-insulin, ukunciphisa i-postprandial plasma non-esterified fatty acids, ukucothisa okanye ukuthintela ukwetyiswa kwamafutha okutya, ukunciphisa amafutha e-visceral, kunye nokukhuthaza ukugcinwa kwe-glucagon-njenge-peptide-1 emathunjini amancinci asezantsi.
Uphononongo kwizigulana ezinengxaki yokutyeba kungqina ukwehla okukhulu kwimeko yohlobo lweswekile yesi-2 njengesiphumo sonyango lwe-orlistat ekhatshwa yindlela yokuphila esempilweni (ukutya okunamafutha asezantsi kunye nokuzilolonga). Ikwakhokelele ekulahlekeni kobunzima obukhulu. Olunye uphononongo olwenziwe abaguli abatyebe kakhulu okanye abagqithisileyo abanesifo seswekile i-2 babandakanya ukulawulwa kwe-120 mg Orlistat kathathu ngemini iinyanga ezi-6 okanye ezili-12. Ukongeza kwisiphumo sokulahleka kobunzima, ukuphuculwa kolawulo lwe-glycemic kwasekwa, kunye nokwehla kokuzila ukutya kweglucose glucose (FPG) kunye nehemoglobin A1c (HbA1c).
Yonke idatha efunyenwe ngamandla iqinisekisa ukusebenza konyango kunye ne-orlistat powder, idityaniswe nokutya okuncitshisiweyo kweekhalori, kwizigulana ezityebileyo nezityebileyo ezifunyenwe zine-2 yeswekile.
3). Uxinzelelo lwegazi phantsi kolawulo kunye ne-Orlistat
Uxinzelelo lwegazi oluphezulu olwaziwa njengexinzelelo lwegazi yimeko yempilo ebonakaliswa luxinzelelo lwegazi ≥ 130 mm Hg okanye uxinzelelo lwegazi diastolic ≥ 80 mm Hg kwaye ichaphazela ngaphezulu kwama-30% abantu abadala kwihlabathi liphela. Ichongwa njengeyona nto iphambili yomngcipheko wezifo zentliziyo ezinje ngesifo sentliziyo kunye nokubetha kodwa ikwanxulunyaniswa nokusilela kwentliziyo, arrhythmia, isifo sezintso esinganyangekiyo kunye nesifo sengqondo esixhalabisayo. Ukukhula koxinzelelo lwegazi kubangelwa kukukhetha impilo ngendlela engafanelekanga njengokungabikho komzimba, kunye nezinye iimeko zempilo ezinje ngeswekile nokutyeba kakhulu.
Ukuthintela i-lipase, i-Orlistat ithintela ukufunxwa kwamanqatha okutya anokuthintela imithambo kunye neziphumo zokuncipha koxinzelelo lwegazi.
Isifundo esiphanda ngeziphumo ze-orlistat ezinciphise ukwehla kobunzima kuxinzelelo lwegazi lwezigulana ezingama-628 zichaze ukwehla kobunzima kunye nokuhla kokubini koxinzelelo lwegazi lwe-diastolic kunye ne-systolic ngenxa yokulawula i-120 mg Orlistat kathathu ngemini unyaka. Ukucuthwa kwe-9.4 mmHg koxinzelelo lwe-systolic kunye ne-7.7 mmHg kuxinzelelo lwe-diastolic kwabhalwa. Ukongeza, ixesha elide lokusetyenziswa kwe-orlistat eyafunyanwa ukuba ikhokelele ekunciphiseni uxinzelelo lwegazi nge-2.5 mmHg yoxinzelelo lwe-systolic kunye ne-1.9 mmHg yoxinzelelo lwegazi lwe-diastolic.
Amanani afunyenwe kwizifundo abonisa izibonelelo zokusebenzisa i-Orlistat kunyango lwegazi oluphezulu lwabantu abatyebe kakhulu okanye abatyebe kakhulu.
4). Ukunciphisa i-cholesterol iyonke kunye ne-LDL nge-Orlistat
I-cholesterol iyonke sisixa se-lipoprotein (LDL), uxinizelelo oluphezulu lwe-lipoprotein (HDL) ye-cholesterol, kunye ne-20% ye-triglycerides. Ukwakha ezindongeni zemithambo yegazi ukwenza i-plaque, i-cholesterol ye-LDL inoxanduva lokunciphisa ngaphakathi kwimithambo kunye nokuvimba ukuhamba kwegazi. Yonyusa umngcipheko kwezempilo kwaye inxulunyaniswa neemeko, ezinje ngengxaki yentliziyo kunye nokubetha.
Ukongeza kwiinzuzo zokulahleka kwesisindo, i-Orlistat iye yaxelwa ukunciphisa i-cholesterol ye-LDL.
Isifundo kubandakanya abaguli abangama-294 abatyebe kakhulu okanye abagqithisileyo bavavanye iziphumo ze-orlistat kubunzima kunye ne-serum lipids. Unyango lweeveki ezingama-24 lubandakanya idosi yemihla ngemihla ye-360 mg Orlistat eyahlulwe kathathu. I-Orlistat yafunyanwa ukunciphisa ubunzima obukhulu kunye ne-cholesterol epheleleyo kunye ne-LDL. Kwaphinda kwagqitywa ukuba isiphumo sokunciphisa i-cholesterol ye-LDL sasizimele kwizibonelelo zokuphulukana nobunzima. Olunye uphononongo lweenyanga ezi-6 olubandakanya abaguli abangama-448 lwaluzinikezele ekuchongeni iziphumo zokunciphisa i-cholesterol ekunciphiseni ukutya kunye nonyango lwe-orlistat. Iziphumo zibonise ukwehla kobunzima obuphakathi kwe-7.4 kg. Kunye noku, ukuncipha okubonakalayo okupheleleyo kunye ne-LDL ye-cholesterol nge-25-30 mg / dL yarekhodwa.
I-Orlistat inesiseko esisisiseko esisekwe kubungqina bokuphucula iimeko ezinokuthi ngokuthe ngqo okanye ngokungathanga ngqo zidityaniswe nokukhuluphala kunye nokuqokelelwa kwamafutha okugqithisileyo emzimbeni. Iziphumo ze-Orlistat zandiswa ngakumbi xa ulawulo lwayo luhamba kunye nokutya okufanelekileyo kunye nokuzilolonga ukuze izigulana zizuze ngokupheleleyo kunyango olulungiselelwe iimfuno zabo ezithile.
Okungakumbi Ouluhlu Powder Ukuphonononga abaye bavavanya
Izigulana ezenze Unyango lwe-Orlistat ziyavuya ukujonga esipilini yonke imihla kwaye zibone iziphumo ezibonakalayo njengamafutha angafunekiyo, i-flab, kunye ne-cellulite eqala ukuphela.
- “Ke ngo-Okthobha ophelileyo ndiye kwagqirha wam ndacela uncedo kuba ubunzima bam bendidandathekile. Ke undibeke kwi-orlistat kwaye ngoku iinyanga ezi-6 ezantsi kumgca ndilula ngo-16kg, ndimkile kubukhulu be-18/20 ukuya kwi-12/14. Eyona nto intle endakha ndayenza. ” -Sez, thatha i-Orlistat Powder ye-1 ukuya kwiinyanga ze-6.
-Uyiqale ngo-Xenical i-13.06.20 nge-18st 9lbs kwaye ngoku ndineminyaka eyi-16st 0.5lbs kwaye ndalahleka i-2st 8.5lbs ukuza kuthi ga ngoku, ayisebenzi ukuba awutyi kakuhle. Kuyakukhuthaza ukuba utye ngokusempumlweni njengokuba usendlini yangasese ngalo lonke ixesha ukuba awutyi kakuhle, ukuza kuthi ga ngoku kulungile! Ibutshintshe nyhani ubomi bam ”- Becks, thatha iOrlistat Powder kwisithuba seenyanga ezi-1 ukuya kwezi-6
- "Xa ndandiqala ukuthatha eli chiza ndandinama-235lbs kwaye kwiveki ezi-4, ubunzima bam bendiyokutsho kwi-220lbs! I-15lbs ngenyanga !! Khange ndide ndizilolonge, ke khawufane ucinge ukuba ingangakanani into enokwenzeka ukuba ndenze njalo…
-Ndikuluhlu lwe-orlistat ukusukela ngoMeyi 2021 kwaye namhlanje (Julayi 2021) Ndilinganisiwe kutyando lwam lwedrr kwaye ndilahlekelwe lilitye le-2 kwiiveki ezisi-7 !! Ndiziva ndimnandi kwaye ndiza kuqhubeka ndisebenzisa i-orlistat ukunceda ndinciphise ubunzima bam. Khange nditshintshe okuninzi kwindlela enditya ngayo ngaphandle kokuba ndiyekile ukutya okutyayo! ” -Isigulana esingaziwayo, thatha i-Orlistat Powder ye-1 ukuya kwiinyanga ze-6.
Ngoba To Cumbane Ubungakanani bePowder From CMOAPI
Thina, kwi-CMOAPI, sisebenze iiyure ezininzi zebhu kwaye sachitha imali eninzi kwibhanki encinci ukuqinisekisa ukuba i-Orlistat Powder ihlangabezana nemigangatho ephezulu yoshishino kwaye iphila kulindeleke kumthengi ngamnye. Izibonelelo ze-orlistat powder yile:
- 7% ubumsulwa
- Isiqinisekiso seGMP kunye neDMF
- Ukuqinisekisa ukubonga okumgangatho ophezulu okuqinisekisiweyo kwiNkqubo yethu yoLawulo loMgangatho.
Ziziphi izibonelelo zakho ngokusebenzisa i-Orlists Powder yethu?
- Ukuthobela yonke imimiselo yoshishino enxulumene nomgangatho wezinto ezisetyenzisiweyo ezisetyenzisiweyo
- Ukuhambisa iimveliso zokugqibela ezikumgangatho ophezulu
- Ukuqinisekisa iziphumo ezibalaseleyo kwizigulana
- Ukuseka umfanekiso wegama elingenakubekwa
I-FAQ kwi-Orlistat Powder
1.Ngaba i-Orlistat powder isebenza ukuba isigulana asityi mafutha?
I-Orlistat powder isebenza ukunciphisa inani lamafutha afunxwe emzimbeni. Ke ngoko ukuthatha i-Orlistat ngesidlo ngaphandle kwamafutha akusebenzi kwaye idosi kufuneka yeqiwe ukunqanda iziphumo ezichaphazelekayo ze-orlistat.
Ngaba i-XENICAL ingathathwa kunye namanye amayeza?
Ukusebenzisa eli yeza kunye naliphi na kula mayeza alandelayo akuqhelekanga, kodwa kunokufuneka kwezinye iimeko:
- Abanciphisi begazi, njenge-warfarin, i-heparin, i-apixaban, i-dabigatran kunye ne-rivaroxaban powder
- Amayeza e-HIV, afana ne-lopinavir, ritonavir, atazanavir, efavirenz, tenofovir kunye ne-emticitabine.
- Ukuxhamla amayeza
- Cyclosporine
- Amiodarone
- Levothyroxine
Lude kangakanani unyango lweXENICAL?
I-Orlistat ayizukuthathwa ngaphezulu kweenyanga ezintandathu ngaphezulu kwekhawuntari (kwi-60 mg yedosi Orlistat). Ukuba isiguli asilahlekanga ubuncinci i-5% yesisindo sabo emva kokuthatha i-Orlistat iinyanga ezintathu, unyango kufuneka luqhubeke.
4.Ingaba i-Orlistat Powder ibangela ukonakala kwesibindi?
I-Orlistat powder ayichongwanga njengesona sizathu ngqo sokulimala kwesibindi kuzo zombini izilingo zangaphambi kweklinikhi kunye nonyango. Nangona kunjalo, ezinye iimeko ezinqabileyo zokulimala kwe-Orlistat powder yesibindi ziye zaxelwa ngabantu abayisebenzisileyo.
I-Orlistat powder inganciphisa umsebenzi we-enzyme ebalulekileyo ebizwa ngokuba yi-carboxylesterase-2 edlala indima ebalulekileyo ekunciphiseni isibindi, izintso, kunye neendlela zesisu. Xa le enzyme ithintelwe, ityhefu enzulu yamalungu abalulekileyo inokwenzeka.
5.Uphi ukuthenga i-Orlistat powderonline?
Kuba abavelisi kunye noxinaniso lwahlukile, iimveliso ezinentengiso ye-orlistat zinamagama egama le-Orlistat ahlukeneyo. Amanqanaba asezantsi e-Orlistat afunyanwa njengamagama egama le-Orlistat anjenge "Alli" kunye ne "Orlos" kwaye anoku-odolwa ngokulula kwi-Intanethi kubavelisi abaninzi be-Orlistat kunye nabathengisi.
Ngeenjongo zobungcali, ukusebenzisa i-Orlistat Powder ngokucoceka okuphezulu kunye nomgangatho obalaseleyo kubaluleke kakhulu. Ke, uku-odola izinto ezisemgangathweni eziphezulu zokulahleka kobunzima kubavelisi abanokuthenjwa kuluncedo.
I-CMOAPI ngomnye wabavelisi be-Orlistat powder abaqinisekisiweyo abanesiko lexesha elide kolu shishino kwaye baqinisekisa ubungakanani obuphezulu kunye nokupakishwa kakuhle kwe-orlistat powder.
Cofa apha ukuya indawo Yyethu Oumkhweli
Beka iodolo yakho apha ukuze uthathe I-CMOAPI Umgangatho ophezulu we-99.7% we-Orlistat Powder ecocekileyo eyenzelwe ukunyibilika ngokwamanqatha. I-Orlistat Powder yethu yi-GMP kunye ne-DMF eqinisekisiweyo, esisisiqinisekiso sokugqibela sokuhambisa iimveliso ezikumgangatho ophezulu kubathengi bethu.
Ucaphulo
- "Ilebheli yoluhlu lwe-US" (PDF). I-FDA. Agasti 2015. Ibuyisiwe nge-18 ku-Epreli 2018. Ukuhlaziywa kweelebhile jonga iphepha lesalathiso le-FDA le-NDA 020766
- UBarbier P, uSchneider F (1987). "Ii-syntheses ze-tetrahydrolipstatin kunye noqwalaselo olupheleleyo lwe-tetrahydrolipstatin kunye ne-lipstatin". IHelvetica Chimica Acta. 70 (1): 196-202. ikhonkco: 10.1002 / hlca.19870700124.
- UBodkin J, uHumphries E, uMcLeod M (2003). "Ukuhlanganiswa konke (-) - tetrahydrolipstatin". Ijenali yaseOstreliya yeKhemistry. 56 (8): 795-803. ikhonkco: 10.1071 / CH03121.
- I-Filippatos, iTheodosios kunye neDerdemezis, iChristos kunye neGazi, iIrene neNakou, iEleni kunye neMikhailidis, iDimitri kunye neElisaf, uMoses. (2008). Iziphumo eziHlangeneyo ze-Orlistat kunye nokuNxibelelana kweziyobisi. Ukhuseleko lweziyobisi: Ijenali yamanye amazwe yonyango lwezonyango kunye namava eziyobisi 31. 53-65. 10.2165 / 00002018-200831010-00005.
- ISharma, AM, kunye neGolay, A. (2002). Iziphumo zokulahleka kobunzima be-orlistat koxinzelelo lwegazi kunye nenqanaba lentliziyo kwizigulana ezityebileyo ezinexinzelelo. Ijenali yoxinzelelo lwegazi, 20(9), 1873–1878. doi.org/10.1097/00004872-200209000-00034.
- Isitayile esinombhalo osezantsi a kupakeji, kunye nebha ngaphezulu kwe i (Oko kukuthi, "allī"), kodwa kwenziwe imali ngokubanzi kwindibano.
- UZhi J, uMelia AT, amaqanda uE, uJoly R, uPatel IH (1995). "Ukuphononongwa kwenkqubo yokufakwa ngaphakathi kwe-orlistat, i-lipase inhibitor, kumavolontiya asempilweni abantu". J kwiKlinikhi Pharmacol. 35 (11): 1103-8. ikhonkco: 10.1002 / j.1552-4604.1995.tb04034.x. IINKCUKACHA:
Amanqaku aKhanyayo
